AZN relationship map
AZN
Astrazeneca PLC
AZNAstrazeneca PLC
AAPGAscentage Pharma Group InternationalADCTADC Therapeutics
2°McKessonunlisted
2°AmerisourceBergenunlisted
2°Cardinal Healthunlisted
ARQTArcutis Biotherapeutics2°Jiangsu Hengrui Medicineunlisted
2°Hangzhou Zhongmei Huadong Pharmaceuticalunlisted
2°Sato Pharmaceuticalunlisted
AXSMAxsome TherapeuticsINSMInsmed2°Resilience Biotechnologies Inc. (Resilience) (formerly Therapure Biopharma Inc.)unlisted
2°PARI Pharma GmbH (PARI)unlisted
2°PPD Development, L.P. (PPD)unlisted
MNPRMonopar Therapeutics2°NorthStarunlisted
MREOMereo BioPharmaRCUSArcus Biosciences2°WuXi Biologicsunlisted
2°Taiho Pharmaceuticalunlisted
2°WuXi Biologics Irelandunlisted
Sells to →
17.00% of NKTR rev10-K
2°UCBunlisted
2°Baxalta (a subsidiary of Takeda Pharmaceutical Company Limited)unlisted
2°Crystalys Therapeuticsunlisted
2°Cutiaunlisted
2°Tricareunlisted
2°NHS Englandunlisted
2°U.S. Department of Veterans Affairs ("VA")unlisted
2°Swedish Orphan Biovitrum ABunlisted
2°Otsuka Pharmaceuticalunlisted
2°Astellasunlisted
2°Astellas Pharmaunlisted
2°Astellasunlisted
2°Falikangunlisted
2°AstraZenecaunlisted
2°Hansoh Pharmaceuticalunlisted
2°ImmuneOnco Biopharmaceuticals (Shanghai)unlisted
2°ImmuneOncounlisted
← Buys from
AZNAstrazeneca PLC
2°McKessonunlisted
2°AmerisourceBergenunlisted
2°Cardinal Healthunlisted
2°Jiangsu Hengrui Medicineunlisted
2°Hangzhou Zhongmei Huadong Pharmaceuticalunlisted
2°Sato Pharmaceuticalunlisted
2°Resilience Biotechnologies Inc. (Resilience) (formerly Therapure Biopharma Inc.)unlisted
2°PARI Pharma GmbH (PARI)unlisted
2°PPD Development, L.P. (PPD)unlisted
2°NorthStarunlisted
2°WuXi Biologicsunlisted
2°Taiho Pharmaceuticalunlisted
2°WuXi Biologics Irelandunlisted
Sells to →
suppliercustomer2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 13:35 ETSources